Loading clinical trials...
Loading clinical trials...
Fecal Biomarker Study for Patients From a Once Daily Study for Efficacy in a Ulcerative Colitis Maintenance Study
The present study will analyze fecal levels of FC and FL in UC patients who relapse (flare) while on a QD or a BID Asacol treatment regimen and compare those levels to levels of FC and FL in UC patients who do not relapse (flare).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Research Facility
Lowell, Arkansas, United States
Research Facility
Anaheim, California, United States
Research Facility
Folsom, California, United States
Research Facility
Los Angeles, California, United States
Research Facility
Merced, California, United States
Research Facility
San Diego, California, United States
Research Facility
Upland, California, United States
Research Facility
Lafayette, Colorado, United States
Research Facility
Torrington, Connecticut, United States
Research Facility
Fort Lauderdale, Florida, United States
Start Date
August 1, 2007
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
May 31, 2013
89
ACTUAL participants
Lead Sponsor
Warner Chilcott
NCT07271069
NCT06975722
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07185009